Echinococcosis is still a serious problem particularly in endemic areas such as South and Central America, Mediterranean countries, and Russia. Furthermore, hydatid cysts of the lung are often indistinguishable from a variety of other pulmonary lesions such as lung tumors
Case presentation
We herein present a 56 year old woman with breast cancer who presented with bilateral pulmonary nodules due to echinococcosis granulosis that mimicked metastatic breast cancer to the lung.
Conclusion
During the evaluation of the malignancies which could metastasize to the lung, it must be kept in mind that the appearance of bilateral multiple pulmonary masses can also be the sign of a pulmonary echinococcosis especially in endemic areas. FDG-PET with its known high negative predictive value in characterizing indeterminate pulmonary nodules >1 cm is very helpful to characterize this kind of lesions.
The online version of this article (doi:10.1186/1477-7819-6-7) contains supplementary material, which is available to authorized users.
Competing interests
The author(s) declare that they have no competing interests.
Authors' contributions
YK drafted the manuscript, ÝS helped in preparing the manuscript, AÝF did literature search and helped with manuscript, MU helped with the nuclear medicine component of manuscript, MLA helped with preperation of manuscript.
All authors read and approved the final manuscript.
Background
Echinococcosis is a parasitic infestation caused by larvae of the tapeworm echinococcus. Although there are four species the vast majority of hydatid disease in humans are caused by echinococcus granulosis which causes cystic echinococcosis and has a worldwide distribution. Echinococcus multilocularis causes alveolar echinococcosis which can be seen less frequently in humans. In cystic echinococcosis humans are an aberrant host and are usually infected by oral ingestion of excrement from an infected dog. Infected red fox has an important role for alveolar echinococcosis [1, 2]. Parasitic eggs turned to larvae form after ingestion in the intestine and migrate to the other organs by penetrating intestinal wall and then develop cystic or alveolar echinococcosis. The liver and lungs are the most common involved organs. Hydatid cysts may rupture, can become secondarily infected, or may infect other organs. Alveolar echinococcosis behaves like a malignant tumor biologically. Humans Echinococcosis is still a serious problem particularly in endemic areas such as South and Central America, Mediterranean countries, Australia and Russia. Furthermore, hydatid cysts of the lung are often indistinguishable from a variety of other pulmonary lesions such as lung tumors [2‐4].
Case presentation
A 56-year old woman admitted with a breast lump, chronic cough and chest pain. There was no medical or family history of note. On physical examination we discovered a palpable mass in the medial outer quadrant of the right breast and ipsilateral palpable axillary and supraclavicular lymph nodes. Mammography and ultrasound revealed a 2 cm nodule with irregular border including micro calcifications which was confirmed to be invasive ductal carcinoma by a fine needle biopsy. Chest radiography and computed tomography showed multiple nodules and masses involving both lungs highly suspicious to be metastatic in origin (Figure 1). Positron Emission Tomography (PET) scans showed increased Fluoro-deoxy-glucose (FDG) uptake in the breast cancer and axillar, supraclavicular lymph nodes as it's expected but there is no FDG uptake in pulmonary lesions suggesting a benign origin (Figure 2). She was coming from the east part of the country where hydatid disease is endemic. Positive indirect hemaglutination test supported the diagnosis of pulmonary echinococcosis. Chemotherapy for Stage IIIC breast cancer (Adriamycin, cyclophosphamid and paclitaxel) and albendazol treatment began for the patient.
×
×
Anzeige
Discussion
Hydatid disease is one of the most important helminthic diseases. Echinococcosis is worldwide in distribution; it occurs most commonly in sheep and cattle-raising areas [4]. Lung is the second most common involved organ but it is hard to distinguish pulmonary echinococcosis from a variety of other pulmonary lesions especially metastatic lesions to the lung. In women, the appearance of metastasis is a frequent complication of breast cancer. The lung is the second most common organ for metastasis of breast cancer after the bone [5]. We present herein a patient with breast cancer who had also bilateral pulmonary multiple masses in different size and irregular shape which were determined by plain X-Ray and thorax CT thought to be metastasis to lung. Despite increased FDG uptake for breast cancer and metastatic lymph nodes, pulmonary nodules and masses had no FDG uptake so we excluded malignancy by FDG-PET scan and decided with a high degree of certainty that they were benign lesions. In fact there is a wide differential diagnosis for multiple nodules and masses with extensive pulmonary involvement on radiography or computed tomography, which includes pulmonary echinococcosis. But they are not as accurate as FDG PET to exclude the metastatic pulmonary lesions especially >1 cm. Needle biopsy or aspiration of the hydatid cysts since anaphylactic shock would not necessary develop when draining a pulmonary abscess or other cystic lesions rather than echinococcosis [2].
A study by Schirrmeister et al showed that whole body FDG PET is as accurate as panel of imaging modalities currently employed and significantly more accurate in detecting multifocal disease, lymph node involvement and distant metastasis [6]. FDG PET has been shown to have impact on the staging and management of recurrent or metastatic breast cancer in cases of suspicion and in a follow-up setting. The current oncological situation can be clarified with a single basic imaging modality [6, 7].
There is no doubt that multiple pulmonary nodules may be commonly seen in patients with inflammatory diseases such as echinococcosis but we want to emphasize in this manuscript that it is hard to differentiate whether these nodules are malign or not especially in patients with malignancy. At this point FDG Pet scan can be helpful by showing the high metabolic activity of the nodules. Even though Stumpe et al [1] found that in patients with alveolar echinococcosis baseline PET scans showed multifocally increased FDG uptake in the hepatic lesions' periphery, liver lesions were FDG negative in patients with cystic echinococcosis.
Conclusion
FDG-PET besides being a strong indicator of malignant lung nodules, is a reliable diagnostic test that can avert needle biopsy of lesions that do not show significant metabolic activity. During the evaluation of the malignancies which could metastasize to the lung, it must be kept in mind that the appearance of bilateral multiple pulmonary masses can also be the sign of a pulmonary echinococcosis especially in endemic areas. FDG-PET with its known high negative predictive value in characterizing indeterminate pulmonary nodules >1 cm is very helpful to characterize this kind of lesions
Anzeige
Acknowledgements
Written informed consent was obtained from the patient for publication of this case report
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Competing interests
The author(s) declare that they have no competing interests.
Authors' contributions
YK drafted the manuscript, ÝS helped in preparing the manuscript, AÝF did literature search and helped with manuscript, MU helped with the nuclear medicine component of manuscript, MLA helped with preperation of manuscript.
All authors read and approved the final manuscript.
Die Therapie von Echinokokkosen sollte immer in spezialisierten Zentren erfolgen. Eine symptomlose Echinokokkose kann – egal ob von Hunde- oder Fuchsbandwurm ausgelöst – konservativ erfolgen. Wenn eine Op. nötig ist, kann es sinnvoll sein, vorher Zysten zu leeren und zu desinfizieren.
Der OP in der Zukunft wird mit weniger Personal auskommen – nicht, weil die Technik das medizinische Fachpersonal verdrängt, sondern weil der Personalmangel es nötig macht.
Seit November 2023 gibt es evidenzbasierte Empfehlungen zum perioperativen Management bei gastrointestinalen Tumoren (POMGAT) auf S3-Niveau. Vieles wird schon entsprechend der Empfehlungen durchgeführt. Wo es im Alltag noch hapert, zeigt eine Umfrage in einem Klinikverbund.
Auch wenn sich Krankenhäuser nachhaltig und grün geben – sie tragen aktuell erheblich zu den CO2-Emissionen bei und produzieren jede Menge Müll. Ein Pilotprojekt aus Bonn zeigt, dass viele Op.-Abfälle wiederverwertet werden können.
Update Chirurgie
Bestellen Sie unseren Fach-Newsletterund bleiben Sie gut informiert.
Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.
Das Webinar beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?
Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.